[go: up one dir, main page]

GR3031504T3 - Use of liquid fluorocarbons to facilitate pulmonary drug delivery - Google Patents

Use of liquid fluorocarbons to facilitate pulmonary drug delivery

Info

Publication number
GR3031504T3
GR3031504T3 GR990402598T GR990402598T GR3031504T3 GR 3031504 T3 GR3031504 T3 GR 3031504T3 GR 990402598 T GR990402598 T GR 990402598T GR 990402598 T GR990402598 T GR 990402598T GR 3031504 T3 GR3031504 T3 GR 3031504T3
Authority
GR
Greece
Prior art keywords
drug delivery
pulmonary drug
liquid fluorocarbons
facilitate pulmonary
lungs
Prior art date
Application number
GR990402598T
Other languages
English (en)
Inventor
Gwen H Rosenberg
Original Assignee
Alliance Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharma filed Critical Alliance Pharma
Publication of GR3031504T3 publication Critical patent/GR3031504T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/913—Breathable liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR990402598T 1994-11-04 1999-10-13 Use of liquid fluorocarbons to facilitate pulmonary drug delivery GR3031504T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/334,688 US5531219A (en) 1994-11-04 1994-11-04 Use of liquid fluorocarbons to facilitate pulmonary drug delivery
PCT/US1995/014280 WO1996014056A1 (en) 1994-11-04 1995-11-02 Use of liquid fluorocarbons to facilitate pulmonary drug delivery

Publications (1)

Publication Number Publication Date
GR3031504T3 true GR3031504T3 (en) 2000-01-31

Family

ID=23308353

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402598T GR3031504T3 (en) 1994-11-04 1999-10-13 Use of liquid fluorocarbons to facilitate pulmonary drug delivery

Country Status (10)

Country Link
US (1) US5531219A (el)
EP (1) EP0789558B1 (el)
JP (1) JPH10508602A (el)
AT (1) ATE182785T1 (el)
AU (1) AU710381B2 (el)
DE (1) DE69511279T2 (el)
DK (1) DK0789558T3 (el)
ES (1) ES2136315T3 (el)
GR (1) GR3031504T3 (el)
WO (1) WO1996014056A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2607021B2 (ja) 1991-05-03 1997-05-07 アライアンス ファーマシューティカル コーポレイション フルオロカーボンの部分液体呼吸
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US5829428A (en) * 1996-05-29 1998-11-03 Alliance Pharmaceutical Corp. Methods and apparatus for reducing the loss of respiratory promoters
WO1998006426A1 (en) * 1996-08-14 1998-02-19 Gram Joergen Brodersen Use of a plasminogen activator for the treatment of pulmonary disorders
NZ336381A (en) 1996-12-30 2000-11-24 Battelle Memorial Institute Formulation and method for treating neoplasms by inhalation
US6451784B1 (en) * 1996-12-30 2002-09-17 Battellepharma, Inc. Formulation and method for treating neoplasms by inhalation
TR199901772T2 (el) * 1997-02-17 1999-09-21 Byk Gulden Lomberg Chemische Fabrik Gmbh
WO2002100432A1 (en) 2001-06-08 2002-12-19 Genaera Corporation Methods for the modulation of il-13
JP4874483B2 (ja) 1999-06-09 2012-02-15 ロバート イー． シーバース 超臨界流体補助ネブライゼーション及びバブル乾燥
JP2004524933A (ja) * 2001-04-11 2004-08-19 カンドラー ミヒャエル 人工呼吸装置
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
CA2413041A1 (fr) * 2002-11-29 2004-05-29 Jean-Paul Praud Un appareil permettant d'effectuer des ventilations liquides totales
GB2422310B (en) * 2004-12-02 2006-12-27 Kaizen Matsumoto Carcinogen solvents in reducing the carcinogen concentration of cells
US7909031B2 (en) * 2005-06-09 2011-03-22 Temple Univesity - Of The Commonwealth System of Higher Education Process for transient and steady state delivery of biological agents to the lung via breathable liquids
DK1962869T3 (da) * 2005-12-21 2013-06-24 Solaeromed Inc Behandling af luftvejssygdomme
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
PE20160789A1 (es) * 2013-11-04 2016-08-17 Univ Texas Composiciones y metodos para admistracion de una enzima a las vias respiratorias de un sujeto
US10034986B2 (en) 2013-11-11 2018-07-31 Crossbay Medical, Inc. Method and apparatus of tubal patency catheter and delivery systems
US9028401B1 (en) 2013-11-11 2015-05-12 Cross Bay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
US10245074B2 (en) 2013-11-11 2019-04-02 Crossbay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
US20180140547A1 (en) * 2015-05-06 2018-05-24 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
US20190201556A1 (en) 2016-05-16 2019-07-04 Mtm Research, Llc Fluorochemical targeted therapies
CA3104821A1 (en) 2018-05-07 2019-11-14 Mtm Research, Llc Photodynamic compositions and methods of use
KR102480355B1 (ko) 2019-10-09 2022-12-23 크로스베이 메디칼 아이엔씨 자궁강 내에 iud를 전달 및 배치하기 위한 방법 및 외번 카테터 장치
CN115605189A (zh) * 2020-05-13 2023-01-13 国立大学法人东京医科齿科大学（Jp） 用于处置呼吸衰竭等所致的低氧状态的对象的药物组合物
US20230380414A1 (en) * 2020-10-12 2023-11-30 Boundless Science, Llc Systems, devices and methods for delivering aerosolized fluorocarbons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
WO1991003267A1 (en) * 1989-08-28 1991-03-21 Sekins K Michael Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
JP2607021B2 (ja) * 1991-05-03 1997-05-07 アライアンス ファーマシューティカル コーポレイション フルオロカーボンの部分液体呼吸
US5209785A (en) * 1991-10-30 1993-05-11 United Technologies Corporation Non-chlorinated solvent dewax process

Also Published As

Publication number Publication date
ES2136315T3 (es) 1999-11-16
EP0789558B1 (en) 1999-08-04
WO1996014056A1 (en) 1996-05-17
AU4101796A (en) 1996-05-31
US5531219A (en) 1996-07-02
JPH10508602A (ja) 1998-08-25
EP0789558A1 (en) 1997-08-20
DE69511279T2 (de) 2000-01-05
DE69511279D1 (de) 1999-09-09
DK0789558T3 (da) 2000-03-06
ATE182785T1 (de) 1999-08-15
AU710381B2 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
GR3031504T3 (en) Use of liquid fluorocarbons to facilitate pulmonary drug delivery
EE200000194A (et) Perforeeritud mikropartiklid ja nende kasutamise meetodid
BG102022A (bg) Дозиращ инхалатор за салметерол
EP0841074A3 (en) Medical apparatus
IL125534A (en) Unit dose of budesonide and use thereof for nasal administration
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
CA2162981A1 (en) Breathing Gas Delivery Method and Apparatus
MY112915A (en) Multiple unit tableted dosage form 1
NO955226D0 (no) Terapautisk preparat for inhalering
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
CA2346791A1 (en) Flow resistance modulated aerosolized active agent delivery
BG101972A (bg) Дозофиксиращ инхалатор за флутиказонпропионат
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
PT813424E (pt) Formas de dosagem farmaceutica oral que contem um inibidor da bomba de protoes e um agente antacido ou alginato
WO1995017156A3 (en) Ethanol substitutes
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
FI971951L (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ITMI20000300A0 (it) Nebulizzatore medico per liquido da utilizzare nella terapia respiratoria e altre applicazioni
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
EP0794769A4 (en) METHOD FOR DISPENSING DRUGS AND COATINGS FOR USE IN THIS METHOD
EP1782798A3 (en) Ascending-dose dosage form
Kumar et al. Lack of cardiovascular stimulation during endotracheal intubation in cardiac surgical patients anesthetized with diazepam-ketamine-pancuronium
AU8855598A (en) Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology
Harrison et al. Interpleural analgesia: Its use, and a complication, in a quadriplegic patient with chronic benign pain.
GEP20002259B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances